Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		Submit


Tuberculosis (TB)





Reported Tuberculosis in the United States, 2018						Print
																Related Pages
										Return to Main Menu
**Appendix A****Tuberculosis Case Definition for Public Health Surveillance**
**(Revised May 13, 2009)**
**Clinical Description**
A chronic bacterial infection caused by *Mycobacterium tuberculosis*complex, usually characterized pathologically by the formation of granulomas. The most common site of infection is the lung, but other organs can be involved.
**Clinical Case Definition**
A case that meets ***all***of the following criteria:
a positive tuberculin skin test result or positive interferon-gamma release assay for *Mycobacterium tuberculosis*;
other signs and symptoms compatible with tuberculosis (TB) (e.g., abnormal chest radiograph, abnormal chest computerized tomography scan or other chest imaging study, or clinical evidence of current disease);
treatment with ≥2 anti-TB medications; and
a completed diagnostic evaluation.**Laboratory Criteria for Diagnosis**
The following 3 criteria are used for diagnosis of TB:
isolation of *M. tuberculosis*complex from a clinical specimen, ****or***
demonstration of *M. tuberculosis*complex from a clinical specimen by nucleic acid amplification test,†***or***
demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or cannot be obtained or is falsely negative or contaminated.**Case Classification**
***Confirmed:***a case that meets the clinical case definition or is laboratory-confirmed.
**Comments****:**A case should not be counted twice within any consecutive 12-month period. However, a case occurring in a patient who previously had verified TB disease should be reported and counted again if >12 months have elapsed since the patient completed therapy. A case should also be reported and counted again if the patient was lost to supervision for >12 months and TB disease can be verified again. Mycobacterial diseases other than those caused by *M. tuberculosis*complex should not be counted in TB morbidity statistics, unless concurrent TB occurs.
* Use of rapid identification techniques for *M. tuberculosis*(e.g., DNA probes and mycolic acid high-pressure liquid chromatography performed on a culture from a clinical specimen) are acceptable under this criterion.
† Nucleic acid amplification tests (NAAT) must be accompanied by culture for mycobacteria species for clinical purposes. A culture isolate of *M. tuberculosis* complex is required for complete drug-susceptibility testing and also genotyping. However, for surveillance purposes, the Centers for Disease Control and Prevention will accept results obtained from NAAT approved by the Food and Drug Administration (FDA) and used according to the approved product labeling on the package insert, or a test produced and validated in accordance with applicable FDA and Clinical Laboratory Improvement Amendments regulations.
							
					
							Last Reviewed:  September 6, 2019						Source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisData and Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City Reports To receive email updates about this page, enter your email address: Email Address			What's this?				Submit
 Error processing SSI file


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue